Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLP-0019- FebriDx® Method Comparison Study Protocol

NCT06746259 is registered in ClinicalTrials.gov with Lumos Diagnostics as lead sponsor.

NCT NCT06746259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06746259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLP-0019- FebriDx® Method Comparison Study Protocol
Lead sponsor
Lumos Diagnostics
Phase
Observational
Overall status
Completed
Start date
December 20, 2024
Completion date
August 31, 2025
Enrollment
800 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infections (aris)